The intestinal microbiota is known to influence local immune homeostasis in the gut and to
shape the developing immune system towards elimination of pathogens and tolerance …

Pseudomonas aeruginosa is one of the most dominant pathogens in cystic fibrosis (CF)
airway disease and contributes to significant inflammation, airway damage, and poorer …

Background The COVID-19 pandemic has intensified interest in how the infection affects the
lung microbiome of critically ill patients and how it contributes to acute respiratory distress …

Although the lungs were considered to be sterile until recently, the advent of molecular
biology techniques, such as polymerase chain reaction, 16 S rRNA sequencing and …

Cystic fibrosis (CF) lung disease has the greatest impact on the morbidity and mortality of
patients suffering from this autosomal-recessive multiorgan disorder. Although CF is a …

Cystic fibrosis (CF) is an inherited genetic disorder which manifests primarily in airway
disease. Recent advances in molecular technologies have unearthed the diverse …

The advent of next generation sequencing has rapidly challenged the paediatric respiratory
physician's understanding of lung microbiology and the role of the lung microbiome in host …

The present treatments for bronchiectasis, which is defined by pathological dilatation of the
airways, are confined to symptom relief and minimizing exacerbations. The condition is …

Microbial co‐infections may contribute to the pulmonary deterioration in COVID‐19 patients
needing intensive care treatment. The present study portrays the extent of co‐infections in …

Background Lung disease as major cause for morbidity in patients with cystic fibrosis (CF)
starts early in life. Its large phenotypic heterogeneity is partially explained by the genotype …